US Army Medical Research Institute of Infectious Diseases
BioInnovation, USAMRIID Develops Panel for Detection of Ebola, Other Filoviruses
NEW YORK (GenomeWeb) – Swiss-based pathogen sequencing analysis firm BioInnovation Solutions today said that it and the US Army Medical Research Institute of Infectious Diseases have developed a panel for the rapid detection and surveillance of filoviruses, such as Ebola and Marburg.
The agreement provides Akonni access to nucleic acid sequences, primers, and probes for several important biothreat agents, which it will incorporate into molecular tests on its TruArray and TruSentry platforms.
Akonni Licenses Biological Threat Materials from USAMRIID to Develop Tests
Akonni plans to use the content to develop products to expand its market presence beyond detection of infectious diseases, including global biosecurity.
Pathogenica Awarded CRADA to Develop Pathogen Identification Technology
The startup will use its using next-generation sequencing-based technology for applications aimed at identifying biothreats.